Plaintiff Gail Ingham, foreground, of O'Fallon, Mo., stands outside the civil courthouse with attorneys Lee Cirsch, from left, Eric Holland and Mark Lanier following a verdict against health care giant Johnson & Johnson, Thursday, July 12, 2018, in St. Louis. A jury awarded nearly $4.7 billion in total damages to 22 women and their families who claimed asbestos in Johnson & Johnson talcum powder contributed to their ovarian cancer in the first case against the company that focused on asbestos in the powder. (Christian Gooden/St. Louis Post-Dispatch via AP)
Plaintiff Gail Ingham, foreground, of O'Fallon, Mo., stands outside the civil courthouse with attorneys Lee Cirsch, from left, Eric Holland and Mark Lanier following a verdict against health care giant Johnson & Johnson, Thursday, July 12, 2018, in St. Louis. A jury awarded nearly $4.7 billion in total damages to 22 women and their families who claimed asbestos in Johnson & Johnson talcum powder contributed to their ovarian cancer in the first case against the company that focused on asbestos in the powder. (Christian Gooden/St. Louis Post-Dispatch via AP)
Plaintiff Gail Ingham, foreground, of O'Fallon, Mo., stands outside the civil courthouse with attorneys Lee Cirsch, from left, Eric Holland and Mark Lanier following a verdict against health care giant Johnson & Johnson, Thursday, July 12, 2018, in St. Louis. A jury awarded nearly $4.7 billion in total damages to 22 women and their families who claimed asbestos in Johnson & Johnson talcum powder contributed to their ovarian cancer in the first case against the company that focused on asbestos in the powder. (Christian Gooden/St. Louis Post-Dispatch via AP)

Correction: Talc Powder-Cancer Lawsuit story

July 13, 2018 04:08 PM